A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

The Roux-en-Y procedure is a type of gastric bypass surgery where the stomach is divided into a small pouch, and part of the small intestine is rerouted to the new pouch. This reduces both food intake and nutrient absorption, leading to significant weight loss and improvements in obesity-related health conditions.

Weight loss tablets are medications designed to help individuals lose weight by suppressing appetite or blocking fat absorption. Common examples include Orlistat, which reduces fat absorption, and phentermine, which is an appetite suppressant. These medications are typically prescribed to individuals with a BMI over 30 or those with obesity-related conditions.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

After sleeve gastrectomy, patients follow a specific diet to help the stomach heal and ensure success in weight loss. The diet starts with liquids, followed by pureed foods, and eventually soft foods before transitioning to solid foods. High-protein, low-fat, and low-sugar meals are critical, along with small, frequent portions.

Slimming injections like Wegovy or Saxenda are used to assist with weight loss by controlling appetite and hunger. These injections are prescribed for individuals who struggle with obesity or weight-related health issues and have not been able to lose weight through diet and exercise alone.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

A bariatric doctor specializes in weight-loss surgery and obesity management. These specialists perform procedures such as gastric bypass, sleeve gastrectomy, and lap band surgery. To find a qualified bariatric doctor near you, consult your healthcare provider or search for local bariatric clinics.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

The bariatric diet is essential for patients who have undergone weight-loss surgery. It’s designed to provide adequate nutrition while supporting weight loss. The diet includes small, protein-rich meals, limited carbohydrates, and restricted fats and sugars. Lifelong adherence to this diet, along with vitamin supplements, is necessary for maintaining health after bariatric surgery.

In the UK, gastroenterology is a well-established medical field. The NHS provides access to gastroenterologists through referrals, though wait times can be significant depending on the region. Private gastroenterology services are available for those seeking faster treatment. The role of a gastroenterologist in the UK is crucial for managing digestive disorders and bariatric surgery outcomes, as well as performing diagnostic and therapeutic procedures such as endoscopies and colonoscopies.

Weight-loss surgery, or bariatric surgery, includes procedures like gastric bypass, sleeve gastrectomy, and gastric banding. These surgeries are recommended for individuals with severe obesity who have not been able to lose weight through diet and exercise alone.

In medical terms, GI stands for Gastrointestinal, referring to the digestive system, which includes the stomach, intestines, and other associated organs. GI disorders encompass a wide range of conditions that affect digestion, including gastritis, irritable bowel syndrome (IBS), and gastrointestinal cancers.

The "Slimming Pen" refers to injectable medications like Saxenda and Wegovy (semaglutide) that help with weight loss. These medications regulate hunger hormones, helping users feel fuller and eat less. They are prescribed for individuals who need additional support in managing their weight, especially when diet and exercise alone aren’t sufficient. They’re increasingly popular in the UK, with potential NHS coverage for certain patients.

The cost of Roux-en-Y (RNY) gastric bypass surgery varies widely depending on the country, hospital, and insurance coverage. In the U.S., it typically ranges between $20,000 and $30,000. In the UK, the procedure may be covered by the NHS if the patient meets specific criteria, or it can be done privately for £8,000 to £15,000.